Author

Carolyn R. Bertozzi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Amy LiiD· 1 shared Benjamin A. H. Smith· 1 shared C. Kimberly TsuiiD· 1 shared Curt R. Fischer· 1 shared David Rabuka· 1 shared David W. MorgensiD· 1 shared Michael C. Bassik· 1 shared Robyn M. Barfield· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amy LiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMar 3, 2019

Systematic identification of regulators of antibody-drug conjugate toxicity using CRISPR-Cas9 screens

C. Kimberly Tsui, Robyn M. Barfield, Curt R. Fischer…·Michael C. Bassik

This study uses CRISPR-Cas9 screens to identify genes regulating antibody-drug conjugate (ADC) toxicity, revealing endolysosomal trafficking regulators and mechanisms of ADC resistance.

DOI 10.1101/557454

humangenetic perturbation / CRISPR

𝕏 PostBluesky